Journal of Experimental & Clinical Cancer Research · 2021 · 66 citations · 35 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer TranscriptomicsGlioblastomaMolecular Tumor ProfilingMyc Family OncogenesNoncoding Rna In CancerTumor Suppressor GenesCell Proliferation IndicesDual-luciferase AssaysLuciferase Reporter AssaysMalignant ProgressionPositive Feedback LoopsRna ImmunoprecipitationRna SequencingRna Sequencing (Rna-seq)
BACKGROUND: Long non-coding RNAs (lncRNAs) have been considered as one type of gene expression regulator for cancer development, but it is not clear how these are regulated. This study aimed to identify a specific lncRNA that promotes glioma progression. METHODS: RNA sequencing (RNA-seq) and quantitative real-time PCR were performed to screen differentially expressed genes. CCK-8, transwell migration, invasion assays, and a mouse xenograft model were performed to determine the functions of TMEM44-AS1. Co-IP, ChIP, Dual-luciferase reporter assays, RNA pulldown, and RNA immunoprecipitation assays were performed to study the molecular mechanism of TMEM44-AS1 and the downstream target. RESULTS: We identified a novel lncRNA TMEM44-AS1, which was aberrantly expressed in glioma tissues, and that increased TMEM44-AS1 expression was correlated with malignant progression and poor survival for patients with glioma. Expression of TMEM44-AS1 increased the proliferation, colony formation, migration, and invasion of glioma cells. Knockdown of TMEM44-AS1 in glioma cells reduced cell proliferation, colony formation, migration and invasion, and tumor growth in a nude mouse xenograft model. Mechanistically, TMEM44-AS1 is directly bound to the SerpinB3, and sequentially activated Myc and EGR1/IL-6 signaling; Myc transcriptionally induced TMEM44-AS1 and directly bound to the promoter and super-enhancer of TMEM44-AS1, thus forming a positive feedback loop with TMEM44-AS. Further studies demonstrated that Myc interacts with MED1 regulates the super-enhancer of TMEM44-AS1. More importantly, a novel small-molecule Myc inhibitor, Myci975, alleviated TMEM44-AS1-promoted the growth of glioma cells. CONCLUSIONS: Our study implicates a crucial role of the TMEM44-AS1-Myc axis in glioma progression and provides a possible anti-glioma therapeutic agent.
35
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte, David A. Orlando, Denes Hnisz et al. · Cell · 2013 · 4.3K citations · Full text
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin, Jakob Lovén, Peter B. Rahl et al. · Cell · 2012 · 1.6K citations · Full text
PVT1 dependence in cancer with MYC copy-number increase
Yuen‐Yi Tseng, Branden S. Moriarity, Wuming Gong et al. · Nature · 2014 · 738 citations
A long noncoding RNA connects c-Myc to tumor metabolism
Chiu-Lien Hung, Ling‐Yu Wang, Yen‐Ling Yu et al. · Proceedings of the National Academy of Sciences · 2014 · 315 citations · Full text